Xconomy -- A decade of hard work is beginning to pay off for breast cancer researchers at Detroit’s Barbara Ann Karmanos Cancer Institute, whose spinoff company, Delphinus Medical Technologies, announced last night it has attracted $8 million in venture capital to help bring its breast cancer imaging device to market.